Clinical Trial

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

Name: A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection — clinical trial record (NCT07367529)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of TQB6411 for Injection in subjects with advanced lung cancer

Protocol Amendment History 2 changes

critical Recruitment opened 2026-05-06

notable Trial sites expanded: 34 -> 37 locations 2026-05-06

Trial Details

NCT Number	NCT07367529
Lead Sponsor	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions	Advanced Lung Cancer
Enrollment	465 participants
Start Date	2026-02-26
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-08